Cancers can develop over the course of years even decades so longer follow-up will be helpful to determine the actual magnitude of effect of these medications on cancer risk, Mavromatis told Healio
Hattori Y, Jojima T, Tomizawa A, Satoh H, Hattori S, Kasai K, Hayashi T: A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells
Glutathione promotes circulation and the ability to walk pain-free for a longer distance
That dual benefit helped expand physician and patient interest well beyond traditional diabetes management
But coverage is more nuanced than a yes-no decision. Insurers may respond to lower GLP-1 prices by increasing restrictions, which are already stringent, as Klebanoff showed in two studies with LDI Senior Fellows Jalpa Doshi and Judith Long, and colleagues